Skip to search formSkip to main contentSkip to account menu

licostinel

Known as: 5-nitro-6,7-dichloro-2,3-quinoxalinedione, 6,7-dichloro-1,4-dihydro-5-nitro-2,3-quinoxalinedione, 6,7-dichloro-5-nitro-2,3-quinoxalinedione 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

ACEA 1021

Broader (2)

Excitatory Amino Acid AntagonistsQuinoxalines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Synthesis of Licostinel
Licostinel, a neuroprotective candidate was synthesized from 3,4-dichloroaniline by amidation, nitration,hydrolysis and reduction… 
2003
2003
In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
2001
2001
The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity
1999
1999
Licostinel. ACEA 1021.
1998
1998
Reevaluation of ACEA 1021 as an antagonist at the strychnine-insensitive glycine site of the N-methyl-d-aspartate receptor
1995
1995
Glycine Receptor Antagonism: Effects of ACEA-1021 on the Minimum Alveolar Concentration for Halothane in the Rat
Background Glycine and glutamate binding sites are allosterically coupled at the N-methyl-n-aspartate (NMDA) receptor complex… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)